Award
Delivery Order #SPE2D226F1567
Delivery Order for Guaifenesin and Dexdrug under Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$33.32
Ceiling
$33.32
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Mar 11, 2026
Identifier
SPE2D226F1567
NAICS
325411
This award is a delivery order contract issued under an existing indefinite delivery vehicle (IDV) held by DMS Pharmaceutical Group Inc., a prominent pharmaceutical manufacturer and distributor. The order specifically procures pharmaceutical supplies of guaifenesin and dex, essential components used in medical treatments. This contract builds upon a larger, competitive-bid IDV awarded in mid-2025, which ensures the steady provision of vital medications such as nicotine polacrilex and diazepam injection to government health agencies. The delivery order represents a focused procurement to address immediate pharmaceutical needs at the Park Ridge, Illinois location. Performance is scheduled for a single day in early 2026, reflecting the timely fulfillment of this specialized requirement. The contract sustains government healthcare capacities by guaranteeing access to critical drugs, thereby supporting public health outcomes. No subcontractors or prior related contracts besides the IDV have been reported for this specific delivery order.
Description
8511971845!GUAIFENESIN AND DEX